packageLorlatinib

lorlatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lorlatinib is an ALK inhibitor used to treat non-small-cell lung carcinoma. It is an approved medicine and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27285820 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lorlatinib
ATC codes:L01ED05
DrugBank:DB12130
PubChem CID:71731823
ChEBI:143117
Wikidata:Q27285820
formula:C21H19FN6O2
molar mass:406.421 g/mol (PubChem CID 71731823)
logP:1.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown